27321338|t|Association of abdominal fat with serum amylase in an older cohort: The Baltimore Longitudinal Study of Aging
27321338|a|Abdominal fat is a major determinant of metabolic diseases in older individuals. Obesity and diabetes are associated with low serum amylase (SA) levels, but the association between SA and metabolic disease is poorly understood. We investigated the association of low SA with diabetes and sex - specific associations of serum amylase with abdominal fat in older adults. In community-dwelling volunteers from the Baltimore Longitudinal Study of Aging (778 participants, age 66.8±13.6 years), we assessed abdominal fat by computed tomography and diabetes status using the American Diabetes Association criteria. Linear regression analyses assessed the cross-sectional associations between abdominal fat and SA, and logistic regression assessed the odds of diabetes, given low SA. In unadjusted analyses, individuals in the lowest SA quartile (<48μ/L) had 1.97 greater odds of diabetes, (95% CI, 1.01-3.83) than those in the highest quartile (⩾80μ/L). This association was no longer significant after adjusting for visceral adipose tissue area (VAT, dm(2)), abdominal subcutaneous adipose tissue (SAT, dm(2)) or BMI. In adjusted analyses, VAT and SAT were significantly associated with SA in both sexes. Among women, SA was more strongly associated with VAT than with SAT or BMI; VAT (β=-0.117±0.048, P<0.001), SAT (β=-0.023±0.025, P=0.346) and BMI (β=-0.0052±0.075, P=0.49). The association between SA and diabetes was explained mainly by abdominal visceral fat. In women, SA was more strongly associated with VAT than with BMI or SAT. These findings provide motivation for future mechanistic studies on SA's role in metabolic diseases.
27321338	15	28	abdominal fat	T017	UMLS:C1563742
27321338	34	39	serum	T031	UMLS:C0229671
27321338	40	47	amylase	T103	UMLS:C0002712
27321338	54	59	older	T098	UMLS:C0001792
27321338	60	66	cohort	T098	UMLS:C0599755
27321338	72	81	Baltimore	T082	UMLS:C0004716
27321338	82	100	Longitudinal Study	T062	UMLS:C0023981
27321338	104	109	Aging	T038	UMLS:C0001811
27321338	110	123	Abdominal fat	T017	UMLS:C1563742
27321338	150	168	metabolic diseases	T038	UMLS:C0025517
27321338	172	177	older	T098	UMLS:C0001792
27321338	178	189	individuals	T098	UMLS:C0237401
27321338	191	198	Obesity	T038	UMLS:C0028754
27321338	203	211	diabetes	T038	UMLS:C0011847
27321338	236	261	serum amylase (SA) levels	T033	UMLS:C0729348
27321338	291	293	SA	T033	UMLS:C0729348
27321338	298	315	metabolic disease	T038	UMLS:C0025517
27321338	377	379	SA	T033	UMLS:C0729348
27321338	385	393	diabetes	T038	UMLS:C0011847
27321338	429	434	serum	T031	UMLS:C0229671
27321338	435	442	amylase	T103	UMLS:C0002712
27321338	448	461	abdominal fat	T017	UMLS:C1563742
27321338	501	511	volunteers	T098	UMLS:C0020155
27321338	521	530	Baltimore	T082	UMLS:C0004716
27321338	531	549	Longitudinal Study	T062	UMLS:C0023981
27321338	553	558	Aging	T038	UMLS:C0001811
27321338	564	576	participants	T098	UMLS:C0679646
27321338	612	625	abdominal fat	T017	UMLS:C1563742
27321338	629	648	computed tomography	T058	UMLS:C0040405
27321338	679	708	American Diabetes Association	T092	UMLS:C1705019
27321338	796	809	abdominal fat	T017	UMLS:C1563742
27321338	814	816	SA	T033	UMLS:C0729348
27321338	822	841	logistic regression	T062	UMLS:C0206031
27321338	863	871	diabetes	T038	UMLS:C0011847
27321338	883	885	SA	T033	UMLS:C0729348
27321338	890	909	unadjusted analyses	T062	UMLS:C0936012
27321338	911	922	individuals	T098	UMLS:C0237401
27321338	937	939	SA	T033	UMLS:C0729348
27321338	983	991	diabetes	T038	UMLS:C0011847
27321338	1121	1149	visceral adipose tissue area	T017	UMLS:C1563740
27321338	1151	1154	VAT	T017	UMLS:C1563740
27321338	1164	1201	abdominal subcutaneous adipose tissue	T017	UMLS:C1563741
27321338	1203	1206	SAT	T017	UMLS:C1563741
27321338	1218	1221	BMI	T201	UMLS:C1305855
27321338	1226	1243	adjusted analyses	T062	UMLS:C0936012
27321338	1245	1248	VAT	T017	UMLS:C1563740
27321338	1253	1256	SAT	T017	UMLS:C1563741
27321338	1292	1294	SA	T033	UMLS:C0729348
27321338	1316	1321	women	T098	UMLS:C0043210
27321338	1323	1325	SA	T033	UMLS:C0729348
27321338	1360	1363	VAT	T017	UMLS:C1563740
27321338	1374	1377	SAT	T017	UMLS:C1563741
27321338	1381	1384	BMI	T201	UMLS:C1305855
27321338	1386	1389	VAT	T017	UMLS:C1563740
27321338	1417	1420	SAT	T017	UMLS:C1563741
27321338	1451	1454	BMI	T201	UMLS:C1305855
27321338	1506	1508	SA	T103	UMLS:C0002712
27321338	1513	1521	diabetes	T038	UMLS:C0011847
27321338	1546	1568	abdominal visceral fat	T017	UMLS:C1563740
27321338	1573	1578	women	T098	UMLS:C0043210
27321338	1580	1582	SA	T103	UMLS:C0002712
27321338	1617	1620	VAT	T017	UMLS:C1563740
27321338	1631	1634	BMI	T201	UMLS:C1305855
27321338	1638	1641	SAT	T017	UMLS:C1563741
27321338	1688	1707	mechanistic studies	T170	UMLS:C2698671
27321338	1711	1715	SA's	T103	UMLS:C0002712
27321338	1724	1742	metabolic diseases	T038	UMLS:C0025517